Lord, Abbett & Co. LLC Baxter International Inc Transaction History

Lord, Abbett & Co. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $824,826 - $909,740	-10,133 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $184,114 - $206,601	-2,507 Reduced 19.83%	10,133 $830,000
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $815,027 - $1.03 Million	12,640 New	12,640 $1.03 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $2.12 Million - $2.69 Million	-34,572 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $77.8 Million - $85.5 Million	-1,100,147 Reduced 96.95%	34,572 $2.67 Million
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $267,864 - $318,456	4,223 Added 0.37%	1,134,719 $83.8 Million
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $15.2 Million - $17.6 Million	243,045 Added 27.39%	1,130,496 $73.5 Million
Q4 2017 Feb 14, 2018	SELL	$61.45 - $66.05 $1.9 Million - $2.04 Million	-30,858 Reduced 3.36%	887,451 $57.4 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $42.1 Million - $45.7 Million	707,852 Added 336.34%	918,309 $57.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	210,457	210,457 $12.7 Million

1,004

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.